About Jubilant Pharmova Ltd
Jubilant Pharmova engaged in six businesses, including Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing of sterile injectables, Contract Research Development and Manufacturing, Generics and Proprietary Novel Drugs businesses.
Founded
1978
CEO
Shyam S Bhartia
Employees
3,786
HQ
Noida, India
Finished Products
1Sales
₹1,324.00Cr2Service Income
₹611.40Cr3Sales of Services
₹88.80Cr4Other Operating Revenue
₹65.50CrRaw Materials
1Raw & Process Matrl. Consumed
₹706.30Cr2Other Purchases
₹14.80Cr3Capsules & Injectables
₹6.50CrAbout Jubilant Pharmova Ltd
Jubilant Pharmova engaged in six businesses, including Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing of sterile injectables, Contract Research Development and Manufacturing, Generics and Proprietary Novel Drugs businesses.
Founded:1978
CEO:Shyam S Bhartia
Employees:3,786
HQ:Noida, India
Finished Products
1Sales
₹1,324.00Cr2Service Income
₹611.40Cr3Sales of Services
₹88.80Cr4Other Operating Revenue
₹65.50CrRaw Materials
1Raw & Process Matrl. Consumed
₹706.30Cr2Other Purchases
₹14.80Cr3Capsules & Injectables
₹6.50CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,185
52W Low
₹786
Volume63.91K
Avg VolumeN/A
Beta0.70
Dividend Yield0.55%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
41.18x
Valuation
P/B Ratio
2.04x
Valuation
EPS
₹22.06
Valuation
Dividend Yield
0.55%
Valuation
ROE
5.62%
Profitability
ROCE
6.41%
Profitability
Revenue by Segment
Contribution & growth by business line
Radiopharma
+8.9%44.9%
₹3,690.1 Cr
Contract Development and Manufactur
+38.0%21.3%
₹1,754.8 Cr
Contract Research, Development and
+5.8%14.8%
₹1,217.3 Cr
Allergy Immunotherapy
+12.0%9.6%
₹785.4 Cr
Generics
+12.9%9.4%
₹773.5 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
3.0%
International
97.0%
Americas and Europe91.9%
Rest of the world5.2%
Within India3.0%
Strategic Relations
Collaborations, joint ventures & subsidiaries
K
Kemira Coatings Ltd
United Kingdom
0.00% stakeN
Noble Chematur
Sweden
0.00% stakeT
Technimont
Italy
0.00% stakeH
Hydrogas
Denmark
0.00% stakeB
Biotim
Belgium
0.00% stakeT
Teutoburg
Germany
0.00% stakeC
Crown Decorative
United Kingdom
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.51x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
7.3%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.